nach oben

The journal of nutrition, health & aging

Erschienen in:

07.03.2016

Combination of recreational soccer and caloric restricted diet reduces markers of protein catabolism and cardiovascular risk in patients with type 2 diabetes

verfasst von: Maysa Vieira de Sousa, R. Fukui, P. Krustrup, S. Dagogo-Jack, M. E. Rossi da Silva

Erschienen in: The journal of nutrition, health & aging | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Moderate calorie-restricted diets and exercise training prevent loss of lean mass and cardiovascular risk. Because adherence to routine exercise recommendation is generally poor, we utilized recreational soccer training as a novel therapeutic exercise intervention in type 2 diabetes (T2D) patients.

Objective

We compared the effects of acute and chronic soccer training plus calorie-restricted diet on protein catabolism and cardiovascular risk markers in T2D.

Design, setting and subjects

Fifty-one T2D patients (61.1±6.4 years, 29 females: 22 males) were randomly allocated to the soccer+diet-group (SDG) or to the dietgroup (DG). The 40-min soccer sessions were held 3 times per week for 12 weeks.

Results

Nineteen participants attended 100% of scheduled soccer sessions, and none suffered any injuries. The SDG group showed higher levels of growth hormone (GH), free fatty acids and ammonia compared with DG. After 12 weeks, insulin-like growth factor binding protein (IGFPB)-3 and glucose levels were lower in SDG, whereas insulin-like growth factor (IGF)-1/ IGFBP-3 ratio increased in both groups. After the last training session, an increase in IGF-1/IGFBP-3 and attenuation in ammonia levels were suggestive of lower muscle protein catabolism.

Conclusions

Recreational soccer training was popular and safe, and was associated with decreased plasma glucose and IGFBP-3 levels, decreased ammoniagenesis, and increased lipolytic activity and IGF-1/IGFBP-3 ratio, all indicative of attenuated catabolism.

Dagogo-Jack S. Glycemic control and chronic diabetes complications. In: Umpierrez GE, editor. Therapy for Diabetes Mellitus and Related Disorders. 6th ed. Alexandria, VA: American Diabetes Association. 2014;668–695.

de Sousa MV, Fukui R, Krustrup P, Pereira RM, Silva PR, Rodrigues AC, de Andrade JL, Hernandez AJ, da Silva ME. Positive effects of football on fitness, lipid profile, and insulin resistance in Brazilian patients with type 2 diabetes. Scand J Med Sci Sports. 2014;24(S1):57–65.CrossRefPubMed

Gregg EW, Chen H, Wagenknecht LE, et al. Association of an Intensive Lifestyle Intervention With Remission of Type 2 Diabetes. JAMA. 2012; 308:2489–2496.CrossRefPubMedPubMedCentral

Karakelides H, Nair KS. Sarcopenia of aging and its metabolic impact. Curr Top Dev Biol. 2005;68:123–48.CrossRefPubMed

Nguyen KH, Yao XH, Moulik S, Mishra S, Nyomba BL. Human IGF binding protein-3 overexpression impairs glucose regulation in mice via an inhibition of insulin secretion. Endocrinology. 2011;152(6):2184–96.CrossRefPubMed

Muzumdar RH, Ma X, Fishman S, Yang X, Atzmon G, Vuguin P, Einstein FH, Hwang D, Cohen P, Barzilai N. Central and opposing effects of IGF-I and IGFbinding protein-3 on systemic insulin action. Diabetes. 2006;55(10):2788–96.CrossRefPubMed

Frystyk J, Skjaerbaek C, Vestbo E, Fisker S, Orskov H. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes. Diabetes Metab Res Rev. 1999;15(5):314–22.CrossRefPubMed

Mohanraj L, Kim HS, Li W, Cai Q, Kim KE, Shin HJ, Lee YJ, Lee WJ, Kim JH, Oh Y. IGFBP-3 inhibits cytokine-induced insulin resistance and early manifestations of atherosclerosis. PLoS One. 2013;8(1):e55084.CrossRefPubMedPubMedCentral

Frystyk J. Exercise and the growth hormone-insulin-like growth factor axis. Med Sci Sports Exerc. 2010;42(1):58–66.CrossRefPubMed

10.

Clemmons DR. Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes. Endocrinol Metab Clin North Am. 2012;41(2):425–43.CrossRefPubMedPubMedCentral

11.

Rajpathak SN, He M, Sun Q, Kaplan RC, Muzumdar R, Rohan TE, Gunter MJ, Pollak M, Kim M, Pessin JE, Beasley J, Wylie-Rosett J, Hu FB, Strickler HD. Insulin-like growth factor axis and risk of type 2 diabetes in women. Diabetes. 2012;61(9):2248–54.CrossRefPubMedPubMedCentral

12.

Kaushal K, Heald AH, Siddals KW, Sandhu MS, Dunger DB, Gibson JM, Wareham NJ. The impact of abnormalities in IGF and inflammatory systems on the metabolic syndrome. Diabetes Care. 2004;27(11):2682–8.CrossRefPubMed

13.

Holt RI, Simpson HL, Sönksen PH. The role of the growth hormone-insulin-like growth factor axis in glucose homeostasis. Diabet Med. 2003;20(1):3–15.CrossRefPubMed

14.

Kaplan RC, McGinn AP, Pollak MN, Kuller LH, Strickler HD, Rohan TE, Cappola AR, Xue X, Psaty BM. Association of total insulin-like growth factor-I, insulinlike growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke. J Clin Endocrinol Metab. 2007;92(4):1319–25.CrossRefPubMed

15.

Sierra-Johnson J, Romero-Corral A, Somers VK, Lopez-Jimenez F, Mälarstig A, Brismar K, Hamsten A, Fisher RM, Hellénius ML. IGF-I/IGFBP-3 ratio: a mechanistic insight into the metabolic syndrome. Clin Sci (Lond). 2009;116(6):507–12.CrossRefPubMed

16.

Silha JV, Gui Y, Murphy LJ. Impaired glucose homeostasis in insulin-like growth factor-binding protein-3-transgenic mice. Am J Physiol Endocrinol Metab. 2002;283(5):E937–45.CrossRefPubMed

17.

Kim JH, Lim S, Choi SH, Kim KM, Yoon JW, Kim KW, Lim JY, Park KS, Jang HC. Sarcopenia: an independent predictor of mortality in community-dwelling older Korean men. J Gerontol A Biol Sci Med Sci. 2014;69(10):1244–52.CrossRefPubMed

18.

Yeap BB, Chubb SA, Ho KK, Setoh JW, McCaul KA, Norman PE, Jamrozik K, Flicker L. IGF1 and its binding proteins 3 and 1 are differentially associated with metabolic syndrome in older men. Eur J Endocrinol. 2010;162(2):249–57.CrossRefPubMed

19.

Kim TN, Choi KM. The implications of sarcopenia and sarcopenic obesity on cardiometabolic disease. J Cell Biochem. Jul;116(7):1171–8

20.

Wilkinson DJ, Smeeton NJ, Watt PW. Ammonia metabolism, the brain and fatigue; revisiting the link. Prog Neurobiol. 2010;91(3):200–19.CrossRefPubMed

21.

Mouadil A, Debout C, Read MH, Morello R, Allouche S, Chapon F. Blood metabolite data in response to maximal exercise in healthy subjects. Clin Physiol Funct Imaging. 2012;32(4):274–81.CrossRefPubMed

22.

Snow RJ, Carey MF, Stathis CG, Febbraio MA, Hargreaves M. Effect of carbohydrate ingestion on ammonia metabolism during exercise in humans. J Appl Physiol. 2000;88(5):1576–80.PubMed

23.

Sousa M, Simões HG, Castro CC, Otaduy MC, Negrão CE, Pereira RM, Madsen K, Silva ME. Carbohydrate supplementation increases intramyocellular lipid stores in elite runners. Metabolism. 2012;61(8):1189–96.CrossRefPubMed

24.

de Sousa MV, Madsen K, Simões HG, Pereira RM, Negrão CE, Mendonça RZ, Takayama L, Fukui R, da Silva ME. Effects of carbohydrate supplementation on competitive runners undergoing overload training followed by a session of intermittent exercise. Eur J Appl Physiol. 2010;109(3):507–16.CrossRefPubMed

25.

Copeland JL, Heggie L. IGF-I and IGFBP-3 during continuous and interval exercise. Int J Sports Med. 2008;29(3):182–7.CrossRefPubMed

26.

Krustrup P, Aagaard P, Nybo L, Petersen J, Mohr M, Bangsbo J. Recreational football as a health promoting activity: a topical review. Scand J Med Sci Sports. 2010;20(S1):1–13.CrossRefPubMed

27.

Randers MB, Nybo L, Petersen J, Nielsen JJ, Christiansen L, Bendiksen M, Brito J, Bangsbo J, Krustrup P (2010). Activity profile and physiological response to football training for untrained males and females, elderly and youngsters: influence of the number of players. Scand J Med Sci Sports. 2010;20(S1): 14–23.CrossRefPubMed

28.

Bangsbo J, Junge A, Dvorak J, Krustrup P. Executive summary: Football for health-prevention and treatment of non-communicable diseases across the lifespan through football. Scand J Med Sci Sports. 2014;24(S1):147–150.CrossRefPubMed

29.

Stokes K. Growth hormone responses to sub-maximal and sprint exercise. Growth Horm IGF Res. 2003;13(5):225–38.CrossRefPubMed

30.

Ehrnborg C, Lange KH, Dall R, Christiansen JS, Lundberg PA, Baxter RC, Boroujerdi MA, Bengtsson BA, Healey ML, Pentecost C, Longobardi S, Napoli R, Rosén T; GH-2000 Study Group. The growth hormone/insulin-like growth factor-I axis hormones and bone markers in elite athletes in response to a maximum exercise test. J Clin Endocrinol Metab. 2003;88(1):394–401.CrossRefPubMed

31.

Wee J, Charlton C, Simpson H, Jackson NC, Shojaee-Moradie F, Stolinski M, Pentecost C, Umpleby AM. GH secretion in acute exercise may result in postexercise lipolysis. Growth Horm IGF Res. 2005;15(6):397–404.CrossRefPubMed

32.

Stokes KA, Nevill ME, Hall GM, Lakomy HK. The time course of the human growth hormone response to a 6 s and a 30 s cycle ergometer sprint. J Sports Sci. 2002;20(6):487–94.CrossRefPubMed

33.

Nguyen KH, Yao XH, Erickson AG, Mishra S, Nyomba BL. Glucose Intolerance in Aging Male IGFBP-3 Transgenic Mice: Differential Effects of Human IGFBP-3 and Its Mutant IGFBP-3 Devoid of IGF Binding Ability. Endocrinology. 2015;156(2):462–74.CrossRefPubMed

34.

Robins JL, Cai Q, Oh Y. The impact of neutrophil proteinase 3 on IGFBP-3 proteolysis in obesity. Intern Med 2014;S6:003

35.

Shim ML, Levitt Katz LE, Davis J, Dotzler WC, Cohen P, Ferry RJ Jr. Insulin-like growth factor binding protein-3 is a novel mediator of apoptosis in insulin-secreting cells. Growth Horm IGF Res. 2004;14(3):216–25.CrossRefPubMedPubMedCentral

36.

Yamada PM, Mehta HH, Hwang D, Roos KP, Hevener AL, Lee KW. Evidence of a role for insulin-like growth factor binding protein (IGFBP)-3 in metabolic regulation. Endocrinology. 2010;151(12):5741–50.CrossRefPubMedPubMedCentral

37.

Wahl P, Zinner C, Achtzehn S, Bloch W, Mester J. Effect of high-and low-intensity exercise and metabolic acidosis on levels of GH, IGF-I, IGFBP-3 and cortisol. Growth Horm IGF Res. 2010;20(5):380–5.CrossRefPubMed

Titel: Combination of recreational soccer and caloric restricted diet reduces markers of protein catabolism and cardiovascular risk in patients with type 2 diabetes
verfasst von: Maysa Vieira de Sousa
R. Fukui
P. Krustrup
S. Dagogo-Jack
M. E. Rossi da Silva
Publikationsdatum: 07.03.2016
Verlag: Springer Paris
Erschienen in: The journal of nutrition, health & aging / Ausgabe 2/2017
Print ISSN: 1279-7707
Elektronische ISSN: 1760-4788
DOI: https://doi.org/10.1007/s12603-015-0708-4

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Background

Objective

Design, setting and subjects

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2017

Factors influencing serum 25-hydroxivitamin D levels and other bone metabolism parameters in healthy older women

Dietary quality is associated with abdominal aortic calcification: A mean of 18-year longitudinal study in community-dwelling older adults

Use of health resources and healthcare costs associated with frailty: The FRADEA study

Depressive symptoms increase the risk of mild neurocognitive disorders among elderly Chinese

Protein enrichment of familiar foods as an innovative strategy to increase protein intake in institutionalized elderly